171 related articles for article (PubMed ID: 371884)
1. Antibodies to maize in patients with Crohn's disease, ulcerative colitis and coeliac disease.
Davidson IW; Lloyd RS; Whorwell PJ; Wright R
Clin Exp Immunol; 1979 Jan; 35(1):147-8. PubMed ID: 371884
[TBL] [Abstract][Full Text] [Related]
2. Circulating antibodies to bovine albumin in ulcerative colitis and Crohn's disease. Characterization of the antibody response.
Falchuk KR; Isselbacher KJ
Gastroenterology; 1976 Jan; 70(1):5-8. PubMed ID: 1245283
[TBL] [Abstract][Full Text] [Related]
3. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease?
Castellino F; Rosina F; Bansi DS; Bauducci M; Touscoz GA; Giorda L; Borghesio E; Bessone MP; Astegiano M; Musso A
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):859-64. PubMed ID: 8574718
[TBL] [Abstract][Full Text] [Related]
7. Cellular and humoral response to Kunin antigen (CA) in ulcerative colitis and Crohn's disease.
Bartnik W; Kałuzewski S
Arch Immunol Ther Exp (Warsz); 1979; 27(4):531-8. PubMed ID: 518259
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic methods in diagnosis of inflammatory bowel disease].
Macura-Biegun A; Błaut A
Przegl Lek; 2002; 59(6):468-71. PubMed ID: 12418289
[TBL] [Abstract][Full Text] [Related]
9. Antigen specificity of circulating anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease.
Kossa K; Coulthart A; Ives CT; Pusey CD; Hodgson HJ
Eur J Gastroenterol Hepatol; 1995 Aug; 7(8):783-9. PubMed ID: 7496870
[TBL] [Abstract][Full Text] [Related]
10. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases.
Colombel JF; Reumaux D; Duthilleul P; Noël LH; Gower-Rousseau C; Paris JC; Cortot A
Gastroenterol Clin Biol; 1992; 16(8-9):656-60. PubMed ID: 1426820
[TBL] [Abstract][Full Text] [Related]
11. Cancer in patients with ulcerative colitis, Crohn's disease and coeliac disease: record linkage study.
Goldacre MJ; Wotton CJ; Yeates D; Seagroatt V; Jewell D
Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):297-304. PubMed ID: 18334873
[TBL] [Abstract][Full Text] [Related]
12. Alterations in serum anti-alpha-galactosyl antibodies in patients with Crohn's disease and ulcerative colitis.
D'Alessandro M; Mariani P; Lomanto D; Bachetoni A; Speranza V
Clin Immunol; 2002 Apr; 103(1):63-8. PubMed ID: 11987986
[TBL] [Abstract][Full Text] [Related]
13. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
Cabral VL; Miszputen SJ; Catapani WR
Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
[TBL] [Abstract][Full Text] [Related]
14. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune reactions against common antigen, small intestine, and colon antigen in patients with Crohn's disease, ulcerative colitis, and cirrhosis of the liver.
Eckhardt R; Heinisch M; Meyer zum Büschenfelde KH
Scand J Gastroenterol; 1976; 11(1):49-54. PubMed ID: 1251132
[TBL] [Abstract][Full Text] [Related]
16. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
[TBL] [Abstract][Full Text] [Related]
17. Differential levels of granzyme B, regulatory cytokines, and apoptosis in Crohn's disease and ulcerative colitis at first presentation.
Jenkins D; Seth R; Kummer JA; Scott BB; Hawkey CJ; Robins RA
J Pathol; 2000 Feb; 190(2):184-9. PubMed ID: 10657017
[TBL] [Abstract][Full Text] [Related]
18. [Role of immune reactions in the pathogenesis of ulcerative colitis and Crohn's disease].
Mackiewicz S
Przegl Lek; 1973; 30(10):838-40. PubMed ID: 4770505
[No Abstract] [Full Text] [Related]
19. Circulating antibodies and leucocyte migration inhibition to colon-associated antigen in ulcerative colitis and Crohn's disease.
Marcussen H; Bendixen G
Scand J Gastroenterol; 1974; 9(2):149-52. PubMed ID: 4206480
[No Abstract] [Full Text] [Related]
20. [Lipid A antibody titers and O antibody titers in Crohn's disease, ulcerative colitis and acute enteritis (author's transl)].
Schüssler P; Kruis W; Marget W
Med Klin; 1976 Oct; 71(44):1898-902. PubMed ID: 825710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
